期刊文献+

口服降糖药的研究进展及临床评价 被引量:25

Research Progress and Clinical Evaluation of Oral Hypoglycemic Drugs
在线阅读 下载PDF
导出
摘要 目的 :分类介绍口服降糖药物的进展和临床应用概况 ,并评价其疗效 ,借以指导其临床正确的应用及合理的个性化选择。方法 :采用近期国内外相关文献进行分析与评价。结果 :口服降糖药物进展迅速 ,为糖尿病的防治拓展了更加广阔的空间。结论 :进行正确应用及合理的个体化选择是促进糖尿病防治水平提高的关键。 OBJECTIVE:To respectively introduce clinical usage and progress in oral hypoglycemic drugs and evaluate their clinical efficacy, in order to instruct proper use of the drugs and rationally individualized choice. METHODS: By collecting literatures in recent years at home and abroad. RESULTS: Many new kinds of oral hypoglycemic drugs made quick advancement in recent years, which provided more ways for treating diabetes. CONCLUSION: Proper use and rationally individualized choice of the drugs are the key points for improving prevention and treatment of diabetes.
出处 《中国医院用药评价与分析》 2005年第1期19-21,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 口服降糖药物 临床评价 临床应用 研究进展 糖尿病 近期 个体化 国内外 概况 分析与评价 type 2 diabetes oral hypoglycemic drugs clinical evaluation review
  • 相关文献

参考文献17

二级参考文献58

  • 1杜曦,秦亚录,冯模强.冠心病心绞痛患者应用曲美他嗪联合氨氯地平治疗的效果及对患者左心室射血分数的影响[J].中国急救医学,2018,38(A01):276-276. 被引量:16
  • 2邹豪,邵元福,朱才娟,邓渝林,马玉杰,陈盛新.医院药品DDD数排序分析的原理及利用[J].中国药房,1996,7(5):215-217. 被引量:1426
  • 3陈新谦 金有豫.新编药物学,第14版[M].人民卫生出版社,1998.532.
  • 4相世亭.口服降糖药-阿卡波糖[J].中国药学杂志,1998,33(4):246-246.
  • 5边振考 房云霞 等.糖尿病的饮食疗法[J].时珍国药研究,1997,8(6):553-553.
  • 6[1]Kramer W, Muller G, Girbig F, et al. Differential interaction of glimepiride and glibenclamide with the βcell sulfonylurea receptor Ⅱ.Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride. Biochim Biophys Acta, 1994, 1191(2):278
  • 7[2]Muller G, Hartz D, Punter J, et al. Differential interaction of glimepiride and glibenclamide with the β-cell sulfonylurea receptor Ⅰ. Binding characteristics. Biochim Biophys Acta, 1994,1191(2):267
  • 8[3]Massi-Bendetti M, Herz M, Pfeiffer C. The effects of acute exercise on metabolic control in type Ⅱ diabetic patients treated with glimepiride and glibenclamide. Horm Metab Res, 1996,28(9) :451
  • 9[4]Geisen K, Vegh A, Krause E, et al. Cardiovascular effects of conventional sulfony1ureas and glimepiride. Horm Metab Res,1996, 28(9):496
  • 10[5]Bijlstra PJ, Lutterman JA, Rusel FG, et al. Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans. Diabetologia, 1996, 39 (9):1083

共引文献270

同被引文献136

引证文献25

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部